BR0311333A - ésteres na posição 20 de camptotecinas - Google Patents

ésteres na posição 20 de camptotecinas

Info

Publication number
BR0311333A
BR0311333A BR0311333-7A BR0311333A BR0311333A BR 0311333 A BR0311333 A BR 0311333A BR 0311333 A BR0311333 A BR 0311333A BR 0311333 A BR0311333 A BR 0311333A
Authority
BR
Brazil
Prior art keywords
esters
camptothecins
compounds
mixtures
individual
Prior art date
Application number
BR0311333-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Mauro Marzi
Domenico Alloatti
Claudio Pisano
Maria Ornella Tinti
Loredana Vesci
Franco Zunino
Original Assignee
Sigma Tau Ind Farmaceuti
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti, Ist Naz Stud Cura Dei Tumori filed Critical Sigma Tau Ind Farmaceuti
Publication of BR0311333A publication Critical patent/BR0311333A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epoxy Compounds (AREA)
BR0311333-7A 2002-05-31 2003-05-28 ésteres na posição 20 de camptotecinas BR0311333A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002RM000305A ITRM20020305A1 (it) 2002-05-31 2002-05-31 Camptotecine con anello lattonico modificato.
PCT/IT2003/000328 WO2003101995A2 (en) 2002-05-31 2003-05-28 Camptothecins with a modified lactone ring

Publications (1)

Publication Number Publication Date
BR0311333A true BR0311333A (pt) 2005-03-15

Family

ID=11456338

Family Applications (2)

Application Number Title Priority Date Filing Date
BR0311333-7A BR0311333A (pt) 2002-05-31 2003-05-28 ésteres na posição 20 de camptotecinas
BR0311329-9A BR0311329A (pt) 2002-05-31 2003-05-28 Camptotecinas com um anel de lactona modificado

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR0311329-9A BR0311329A (pt) 2002-05-31 2003-05-28 Camptotecinas com um anel de lactona modificado

Country Status (22)

Country Link
US (1) US7273873B2 (enExample)
EP (2) EP1511752B3 (enExample)
JP (1) JP4693410B2 (enExample)
KR (1) KR101042042B1 (enExample)
CN (1) CN1656100A (enExample)
AR (1) AR040139A1 (enExample)
AT (2) ATE403659T1 (enExample)
AU (2) AU2003241160B2 (enExample)
BR (2) BR0311333A (enExample)
CA (2) CA2485201C (enExample)
CY (2) CY1107311T1 (enExample)
DE (2) DE60322754D1 (enExample)
DK (2) DK1719775T3 (enExample)
ES (2) ES2312090T3 (enExample)
IT (1) ITRM20020305A1 (enExample)
MX (1) MXPA04011682A (enExample)
PE (1) PE20050120A1 (enExample)
PL (1) PL374346A1 (enExample)
PT (2) PT1719775E (enExample)
SI (2) SI1719775T1 (enExample)
TW (1) TWI325866B (enExample)
WO (1) WO2003101995A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2852606A1 (fr) * 2003-03-18 2004-09-24 Inst Nat Sante Rech Med Moyens pour inhiber simultanement l'expression de plusieurs genes impliques dans une pathologie
ITRM20030344A1 (it) 2003-07-14 2005-01-15 Ist Naz Stud Cura Dei Tumori 7-n-poliamminoalchil(ossi)imminometilcamptotecine recanti gruppi protettivi.
ES2400607T3 (es) * 2007-08-01 2013-04-11 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Forma cristalina ll de 7-(dimetoxi-metil)camptotecina, su uso como compuesto intermedio y productos obtenidos a partir de la misma
CN102746314B (zh) * 2011-04-18 2016-07-06 华东师范大学 含有稳定7元内酯环的喜树碱类化合物、制备方法和用途
CN104530066A (zh) * 2015-01-06 2015-04-22 华东师范大学 一类新型高喜树碱衍生物、制备方法和用途
WO2019222272A1 (en) 2018-05-14 2019-11-21 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
BR112021022008A2 (pt) 2019-05-14 2022-05-17 Nuvation Bio Inc Compostos de direcionamento a receptor de hormônio nuclear anticâncer
TW202131930A (zh) 2019-11-13 2021-09-01 美商諾維雪碧歐公司 抗癌核荷爾蒙受體標靶化合物
WO2022204184A1 (en) 2021-03-23 2022-09-29 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
AU2022269568A1 (en) 2021-05-03 2023-11-16 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
JP2025532843A (ja) * 2022-09-28 2025-10-03 ニューベイション・バイオ・インコーポレイテッド 抗がん核内ホルモン受容体標的化化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57116076A (en) * 1981-01-09 1982-07-19 Yakult Honsha Co Ltd Novel camptothecin derivative and its preparation
US4399276A (en) * 1981-01-09 1983-08-16 Kabushiki Kaisha Yakult Honsha 7-Substituted camptothecin derivatives
FR2532591A1 (fr) 1982-09-02 1984-03-09 Hutchinson Nouveau dispositif de securite pour pneumatiques de vehicules ou autres engins
CN1114608C (zh) * 1995-06-21 2003-07-16 科学研究与运用咨询公司 喜树碱类似物、其制备方法和药物应用及其药物组合物
ES2175919T3 (es) * 1999-03-09 2002-11-16 Sigma Tau Ind Farmaceuti Derivados del camptothecin con actividad antitumoral.

Also Published As

Publication number Publication date
ITRM20020305A0 (it) 2002-05-31
JP2005531602A (ja) 2005-10-20
EP1511752B1 (en) 2006-09-13
EP1511752B3 (en) 2010-03-10
WO2003101995A2 (en) 2003-12-11
DK1511752T5 (da) 2010-06-14
EP1511752B8 (en) 2007-04-18
DE60308368D1 (de) 2006-10-26
CY1107311T1 (el) 2012-11-21
ES2273002T7 (es) 2011-08-01
US20050154003A1 (en) 2005-07-14
TW200404806A (en) 2004-04-01
DE60308368T3 (de) 2010-09-16
ITRM20020305A1 (it) 2003-12-01
WO2003101995A3 (en) 2004-02-19
SI1719775T1 (sl) 2009-04-30
ATE339422T1 (de) 2006-10-15
AU2009236044B2 (en) 2011-03-24
PL374346A1 (en) 2005-10-17
WO2003101995A8 (en) 2004-12-23
PT1511752E (pt) 2007-01-31
BR0311329A (pt) 2005-02-22
TWI325866B (en) 2010-06-11
AU2003241160B2 (en) 2009-08-20
AR040139A1 (es) 2005-03-16
DE60322754D1 (de) 2008-09-18
CA2706635A1 (en) 2003-12-11
JP4693410B2 (ja) 2011-06-01
MXPA04011682A (es) 2005-03-31
CA2485201A1 (en) 2003-12-11
CN1656100A (zh) 2005-08-17
EP1719775A1 (en) 2006-11-08
CA2485201C (en) 2010-11-02
EP1719775B1 (en) 2008-08-06
ES2312090T3 (es) 2009-02-16
KR101042042B1 (ko) 2011-06-16
AU2009236044B8 (en) 2011-07-21
PE20050120A1 (es) 2005-03-04
US7273873B2 (en) 2007-09-25
ES2273002T3 (es) 2007-05-01
SI1511752T1 (sl) 2007-02-28
ATE403659T1 (de) 2008-08-15
DE60308368T2 (de) 2007-09-06
DK1719775T3 (da) 2008-11-17
AU2003241160A1 (en) 2003-12-19
AU2009236044A8 (en) 2011-07-21
AU2009236044A1 (en) 2009-12-03
EP1511752A2 (en) 2005-03-09
PT1719775E (pt) 2008-09-30
DK1511752T3 (da) 2007-01-29
KR20050036909A (ko) 2005-04-20
CY1108793T1 (el) 2014-04-09

Similar Documents

Publication Publication Date Title
EA200501009A1 (ru) Замещённые пирролопиразольные производные в качестве ингибиторов киназы
ATE495155T1 (de) Heterocyclische inhibitoren von mek
EA200400361A1 (ru) Производные алкинарилнафтиридин-4(1h)-онов в качестве ингибитора фосфодиэстеразы типа iv
SE0202463D0 (sv) Novel compounds
BRPI0514372A (pt) inibidores de tiazol de frutose 1, 6-bisfosfatase
DE60334536D1 (de) Furylverbindungen
SE0401970D0 (sv) Novel compounds
SE0302323D0 (sv) Novel compounds
SE0104250D0 (sv) Heterocyclic compounds
BR0311333A (pt) ésteres na posição 20 de camptotecinas
BRPI0409105A (pt) análogos de quinobenzoxazina substituìdos
SE0300908D0 (sv) Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
SE0301701D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
PT2112154E (pt) Ésteres na posição 20 de camptotecinas
SE0203303D0 (sv) Novel Compounds
PA8581701A1 (es) Derivados de indolilo
SE0300105D0 (sv) Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof
SE0203300D0 (sv) Novel Compounds
EA200300272A1 (ru) Новые производные хиназолина, способ их получения и фармацевтические композиции, содержащие их
SE0300103D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0301445D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
ATE491709T1 (de) Pyrrolidinohydrochinazoline
SE0203301D0 (sv) Novel Compounds
SE0300104D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0400285D0 (sv) Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2465 DE 03-04-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.